|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.255 CHF | +9.76% |
|
+28.86% | +21.93% |
Business description: DocMorris AG

Number of employees: 1,337
Sales by Activity: DocMorris AG
| Fiscal Period: December | 2021 (CHF) | 2022 (CHF) | 2023 (CHF) | 2024 (CHF) | 2025 (CHF) |
|---|---|---|---|---|---|
Germany | 1.02B | 859M | 907M | 954M | 1.06B |
Europe | 81.94M | 70.45M | 62.08M | 63.1M | 63.12M |
Eliminations | -6.99M | -7.52M | - | - | - |
Switzerland | 627M | 687M | - | - | - |
Geographical breakdown of sales: DocMorris AG
| Fiscal Period: December | 2021 (CHF) | 2022 (CHF) | 2023 (CHF) | 2024 (CHF) | 2025 (CHF) |
|---|---|---|---|---|---|
Germany | 1.02B | 859M | 907M | 954M | 1.06B |
Other | 81.88M | 70.45M | 62.08M | 63.1M | 63.12M |
Switzerland | 620M | 679M | - | - | - |
Executive Committee: DocMorris AG
| Manager | Title | Age | Since |
|---|---|---|---|
Walter Hess
CEO | Chief Executive Officer | 61 | 2022-04-27 |
Daniel Wüest
DFI | Director of Finance/CFO | 56 | 2024-09-30 |
Pablo Ros Gomez
CTO | Chief Tech/Sci/R&D Officer | - | 2024-10-31 |
Kaspar Niklaus
COO | Chief Operating Officer | 58 | 2022-10-31 |
Daniel Grigat
IRC | Investor Relations Contact | - | 2022-07-31 |
Composition of the Board of Directors: DocMorris AG
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 68 | 2022-04-27 | |
| Chairman | 71 | 2010-03-31 | |
| Director/Board Member | 63 | 2019-05-22 | |
Florian Seubert
BRD | Director/Board Member | 53 | 2019-05-22 |
Andréa Belliger
BRD | Director/Board Member | 56 | 2020-12-31 |
Rong Rong Hu
BRD | Director/Board Member | 46 | 2021-12-31 |
Holdings: DocMorris AG
| Name | Equities | % | Valuation |
|---|---|---|---|
DOCMORRIS AG 6.87% | 3,510,712 | 6.87% | 21 M $ |
Company details: DocMorris AG

Group companies: DocMorris AG
| Name | Category and Sector |
|---|---|
Zur Rose Finance BV
Zur Rose Finance BV Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity |
Finance/Rental/Leasing
|
Zur Rose Finance BV
Zur Rose Finance BV Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity |
Finance/Rental/Leasing
|
Other Drug Retailers
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9.76% | +28.86% | -63.45% | -80.88% | 408M | ||
| +0.78% | -4.80% | +38.16% | -14.47% | 19.87B | ||
| +0.85% | +2.16% | +3.72% | -16.99% | 9.7B | ||
| -0.08% | -4.63% | -8.93% | -1.94% | 5.95B | ||
| +3.28% | +1.26% | -21.02% | +16.90% | 4.34B | ||
| +1.51% | -0.04% | -19.70% | -25.44% | 3.99B | ||
| -1.30% | +1.81% | -6.65% | -40.38% | 3.74B | ||
| +0.81% | -1.30% | +2.69% | -41.47% | 2.91B | ||
| +1.18% | -0.39% | -1.53% | +9.58% | 2.86B | ||
| 0.00% | -4.77% | +61.81% | - | 2.38B | ||
| Average | +1.53% | +1.81% | -1.49% | -21.68% | 5.62B | |
| Weighted average by Cap. | +0.85% | -1.55% | +11.95% | -14.30% |
Sector
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ROSE Stock
- Company DocMorris AG
Select your edition
All financial news and data tailored to specific country editions

















